Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, Szeitz B, Rezeli M, Rivard C, Hirsch FR, Brcic L, Popper H, Kern I, Kovacevic M, Skarda J, Mittak M, Marko-Varga G, Bogos K, Renyi-Vamos F, Hoda MA, Klikovits T, Hoetzenecker K, Schelch K, Laszlo V, Dome B. Megyesfalvi Z, et al. Among authors: schelch k. J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25. J Pathol. 2022. PMID: 35489038 Free PMC article.
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.
Hoda MA, Münzker J, Ghanim B, Schelch K, Klikovits T, Laszlo V, Sahin E, Bedeir A, Lackner A, Dome B, Setinek U, Filipits M, Eisenbauer M, Kenessey I, Török S, Garay T, Hegedus B, Catania A, Taghavi S, Klepetko W, Berger W, Grusch M. Hoda MA, et al. Among authors: schelch k. Br J Cancer. 2012 Dec 4;107(12):1978-86. doi: 10.1038/bjc.2012.519. Epub 2012 Nov 20. Br J Cancer. 2012. PMID: 23169291 Free PMC article.
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Schelch K, Hoda MA, Klikovits T, Münzker J, Ghanim B, Wagner C, Garay T, Laszlo V, Setinek U, Dome B, Filipits M, Pirker C, Heffeter P, Selzer E, Tovari J, Torok S, Kenessey I, Holzmann K, Grasl-Kraupp B, Marian B, Klepetko W, Berger W, Hegedus B, Grusch M. Schelch K, et al. Am J Respir Crit Care Med. 2014 Oct 1;190(7):763-72. doi: 10.1164/rccm.201404-0658OC. Am J Respir Crit Care Med. 2014. PMID: 25188816
Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Döme B, Grusch M, Hegedüs B, Berger W. Hoda MA, et al. Among authors: schelch k. Mol Cancer Ther. 2016 Oct;15(10):2357-2369. doi: 10.1158/1535-7163.MCT-15-0846. Epub 2016 Aug 10. Mol Cancer Ther. 2016. PMID: 27512118
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
Schelch K, Wagner C, Hager S, Pirker C, Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, Marian B, Holzmann K, Grasl-Kraupp B, Krupitza G, Laszlo V, Klikovits T, Dome B, Hegedus B, Garay T, Reid G, van Zandwijk N, Klepetko W, Berger W, Grusch M, Hoda MA. Schelch K, et al. Carcinogenesis. 2018 Apr 5;39(4):534-545. doi: 10.1093/carcin/bgy018. Carcinogenesis. 2018. PMID: 29635378
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M. Vlacic G, et al. Among authors: schelch k. Cells. 2019 Sep 16;8(9):1091. doi: 10.3390/cells8091091. Cells. 2019. PMID: 31527449 Free PMC article.
Activin A: an emerging target for improving cancer treatment?
Ries A, Schelch K, Falch D, Pany L, Hoda MA, Grusch M. Ries A, et al. Among authors: schelch k. Expert Opin Ther Targets. 2020 Oct;24(10):985-996. doi: 10.1080/14728222.2020.1799350. Epub 2020 Aug 6. Expert Opin Ther Targets. 2020. PMID: 32700590 Review.
42 results